{"id":"cggv:ab4cfcff-be99-4c82-ab33-8451b5ed5b0cv1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:ab4cfcff-be99-4c82-ab33-8451b5ed5b0c_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10066","date":"2024-04-24T16:00:00.000Z","role":"Approver"},{"id":"cggv:ab4cfcff-be99-4c82-ab33-8451b5ed5b0c_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10066","date":"2024-07-02T15:42:13.249Z","role":"Publisher"}],"curationReasons":{"id":"cg:NewCuration"},"evidence":[{"id":"cggv:ab4cfcff-be99-4c82-ab33-8451b5ed5b0c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:ab4cfcff-be99-4c82-ab33-8451b5ed5b0c_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:afdde03b-00ec-4e8f-b084-2b0d6804283b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:3d7c9178-6582-49fd-a670-a9ea4488b882","type":"Finding","demonstrates":{"id":"cg:GeneExpressionA"},"dc:description":"Figure 3: Quantitative RT-PCR uncovered expression of RPGRIP1L in multiple organs during early development, including the brain, forelimbs, and kidneys\n","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/17558409","type":"dc:BibliographicResource","dc:abstract":"Cerebello-oculo-renal syndrome (CORS), also called Joubert syndrome type B, and Meckel (MKS) syndrome belong to the group of developmental autosomal recessive disorders that are associated with primary cilium dysfunction. Using SNP mapping, we identified missense and truncating mutations in RPGRIP1L (KIAA1005) in both CORS and MKS, and we show that inactivation of the mouse ortholog Rpgrip1l (Ftm) recapitulates the cerebral, renal and hepatic defects of CORS and MKS. In addition, we show that RPGRIP1L colocalizes at the basal body and centrosomes with the protein products of both NPHP6 and NPHP4, known genes associated with MKS, CORS and nephronophthisis (a related renal disorder and ciliopathy). In addition, the RPGRIP1L missense mutations found in CORS individuals diminishes the interaction between RPGRIP1L and nephrocystin-4. Our findings show that mutations in RPGRIP1L can cause the multiorgan phenotypic abnormalities found in CORS or MKS, which therefore represent a continuum of the same underlying disorder.","dc:creator":"Delous M","dc:date":"2007","dc:title":"The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome."},"rdfs:label":"Figure 3 "}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"cggv:3fd41e5b-ede9-42c2-8905-709dfef665ba","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:5ef9b767-3999-48c1-83ae-7c1c778452f1","type":"Finding","demonstrates":{"id":"obo:MI_0915"},"dc:description":"NPHP4 causes another ciliopathy MONDO:0011752","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/17558407","type":"dc:BibliographicResource","dc:abstract":"Protein-protein interaction analyses have uncovered a ciliary and basal body protein network that, when disrupted, can result in nephronophthisis (NPHP), Leber congenital amaurosis, Senior-LÃ¸ken syndrome (SLSN) or Joubert syndrome (JBTS). However, details of the molecular mechanisms underlying these disorders remain poorly understood. RPGRIP1-like protein (RPGRIP1L) is a homolog of RPGRIP1 (RPGR-interacting protein 1), a ciliary protein defective in Leber congenital amaurosis. We show that RPGRIP1L interacts with nephrocystin-4 and that mutations in the gene encoding nephrocystin-4 (NPHP4) that are known to cause SLSN disrupt this interaction. RPGRIP1L is ubiquitously expressed, and its protein product localizes to basal bodies. Therefore, we analyzed RPGRIP1L as a candidate gene for JBTS and identified loss-of-function mutations in three families with typical JBTS, including the characteristic mid-hindbrain malformation. This work identifies RPGRIP1L as a gene responsible for JBTS and establishes a central role for cilia and basal bodies in the pathophysiology of this disorder.","dc:creator":"Arts HH","dc:date":"2007","dc:title":"Mutations in the gene encoding the basal body protein RPGRIP1L, a nephrocystin-4 interactor, cause Joubert syndrome."},"rdfs:label":"Figure 2"}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"cggv:6ef6ee60-c1b1-45a8-a0c5-039a242604db","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:fd78f7cb-ca1a-4ffd-a047-95dfb860565b","type":"Finding","demonstrates":{"id":"cg:BiochemicalFunctionB"},"dc:description":"The disease occurs due to dysfunction of cilia.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/29650680","type":"dc:BibliographicResource","dc:abstract":"Ciliopathies are life-threatening human diseases caused by defective cilia. They can often be traced back to mutations of genes encoding transition zone (TZ) proteins demonstrating that the understanding of TZ organisation is of paramount importance. The TZ consists of multimeric protein modules that are subject to a stringent assembly hierarchy. Previous reports place Rpgrip1l at the top of the TZ assembly hierarchy in ","dc:creator":"Wiegering A","dc:date":"2018","dc:title":"Cell type-specific regulation of ciliary transition zone assembly in vertebrates."},"rdfs:label":"Figure 1. "}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5},{"id":"cggv:ab4cfcff-be99-4c82-ab33-8451b5ed5b0c_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:afeda192-d043-442a-a440-6dea4bd834e7","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:7ba5e024-51aa-499e-8be8-1749f9ade8ce","type":"FunctionalAlteration","dc:description":"The amount of Nphp1, Invs and Cep290 was decreased at the ciliary TZ, the cilia length is increased.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650680","rdfs:label":"Figure 8"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"cggv:ab4cfcff-be99-4c82-ab33-8451b5ed5b0c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:33589860-94d5-493f-91c9-fb11f44f0719","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:de14ca14-bb6f-4651-9b81-16b0abd8f1c8","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"The similar kidney phenotype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29650680","rdfs:label":"Figure 7"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"cggv:a7d6d77d-a93c-45f7-9763-0b1bd04a0077","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:38905ed6-4985-46d5-a30f-e9050af1667f","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"Brain, kidney, and liver features are same and other phenotypes are also very similar","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558409","rdfs:label":"Figure 2"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"cggv:ab4cfcff-be99-4c82-ab33-8451b5ed5b0c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:546a6897-74b9-40a5-ba4e-29094824ab56_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:546a6897-74b9-40a5-ba4e-29094824ab56","type":"Proband","allele":[{"id":"cggv:7f8e09bb-1545-4073-b940-670def78d238","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015272.5(RPGRIP1L):c.2614C>T (p.Gln872Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA130771"}},{"id":"cggv:c9d0cbe0-e08d-44fb-bf8b-4d1e81f65fac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015272.5(RPGRIP1L):c.1033C>T (p.Gln345Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114732"}}],"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0100259","obo:HP_0000107","obo:HP_0000568","obo:HP_0006487","obo:HP_0002085","obo:HP_0002323","obo:HP_0001408"],"secondTestingMethod":"Linkage analysis","sex":"UnknownEthnicity","variant":[{"id":"cggv:adcc1a67-6a89-41f0-8873-cfc88cc289fb_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:c9d0cbe0-e08d-44fb-bf8b-4d1e81f65fac"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558409"},{"id":"cggv:13d2c55a-0b95-44f0-8152-4f6f02bda72f_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:7f8e09bb-1545-4073-b940-670def78d238"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558409"}],"rdfs:label":"F2MKS 05/206"},{"id":"cggv:adcc1a67-6a89-41f0-8873-cfc88cc289fb","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:adcc1a67-6a89-41f0-8873-cfc88cc289fb_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:13d2c55a-0b95-44f0-8152-4f6f02bda72f","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:13d2c55a-0b95-44f0-8152-4f6f02bda72f_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:ce0a167d-df09-4534-a931-a0f87c9ce2ac_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:ce0a167d-df09-4534-a931-a0f87c9ce2ac","type":"Proband","allele":{"id":"cggv:7cf892d0-1094-45f7-b581-6b6b2338fbf1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015272.5(RPGRIP1L):c.2083G>C (p.Ala695Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251694"}},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0003774","obo:HP_0000657","obo:HP_0001251","obo:HP_0000639","obo:HP_0002419","obo:HP_0000090","obo:HP_0002650"],"secondTestingMethod":"Linkage analysis","sex":"UnknownEthnicity","variant":{"id":"cggv:03836242-7399-4cd9-8c28-6d235520a5ae_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:7cf892d0-1094-45f7-b581-6b6b2338fbf1"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558409"},"rdfs:label":"F42-1"},{"id":"cggv:03836242-7399-4cd9-8c28-6d235520a5ae","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:03836242-7399-4cd9-8c28-6d235520a5ae_variant_evidence_item"}],"strengthScore":0.05,"dc:description":"homozygous variant with no supporting functional evidence"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:ab4cfcff-be99-4c82-ab33-8451b5ed5b0c_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:744a1ff8-2c26-4679-8dfa-dc5d5da31a0c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:744a1ff8-2c26-4679-8dfa-dc5d5da31a0c","type":"Proband","allele":{"id":"cggv:1b844b97-a08a-42ec-bd25-e184ac66f1d3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015272.5(RPGRIP1L):c.1721del (p.Tyr574LeufsTer27)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA279450"}},"firstTestingMethod":"Chromosomal microarray","phenotypes":["obo:HP_0001251","obo:HP_0002419","obo:HP_0000496","obo:HP_0012758","obo:HP_0000083"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:79037a4f-6b80-4638-a6cc-e316bbf13cbd_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1b844b97-a08a-42ec-bd25-e184ac66f1d3"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558407"},"rdfs:label":"UW43, V-1"},{"id":"cggv:79037a4f-6b80-4638-a6cc-e316bbf13cbd","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:79037a4f-6b80-4638-a6cc-e316bbf13cbd_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downgraded due to homozygosity"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:a69d2c32-f80a-4b3f-83cc-849060b5aa60_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:a69d2c32-f80a-4b3f-83cc-849060b5aa60","type":"Proband","allele":{"id":"cggv:79553b49-cd3c-4c1f-a873-f9920ef2a5cf","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015272.5(RPGRIP1L):c.2305-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA279339"}},"firstTestingMethod":"Chromosomal microarray","phenotypes":["obo:HP_0000496","obo:HP_0001251","obo:HP_0002419","obo:HP_0012758"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:fca2b40f-f53e-4e14-8e59-e3ac71ff05eb_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:79553b49-cd3c-4c1f-a873-f9920ef2a5cf"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558407"},"rdfs:label":"UW42, IV-1"},{"id":"cggv:fca2b40f-f53e-4e14-8e59-e3ac71ff05eb","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:fca2b40f-f53e-4e14-8e59-e3ac71ff05eb_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downgraded due to homozygosity"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:f6ffc114-afb4-4283-8b94-0b33589bce8b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:f6ffc114-afb4-4283-8b94-0b33589bce8b","type":"Proband","allele":[{"id":"cggv:6971e59e-cf70-4ac7-88ea-e66e4a27bb7c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015272.5(RPGRIP1L):c.697A>T (p.Lys233Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251686"}},{"id":"cggv:bf593f8f-2159-4269-b3a0-3806377626ef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015272.5(RPGRIP1L):c.1843A>C (p.Thr615Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251689"}}],"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001251","obo:HP_0003774","obo:HP_0000657","obo:HP_0001249","obo:HP_0002857","obo:HP_0000090","obo:HP_0000508"],"secondTestingMethod":"Linkage analysis","sex":"UnknownEthnicity","variant":[{"id":"cggv:1a46845e-fede-415f-a8e6-2e13ec70c7c2_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:6971e59e-cf70-4ac7-88ea-e66e4a27bb7c"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558409"},{"id":"cggv:2dfba404-3d8e-42d9-a69c-78f35102b48b_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:bf593f8f-2159-4269-b3a0-3806377626ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558409"}],"rdfs:label":"F222-1"},{"id":"cggv:2dfba404-3d8e-42d9-a69c-78f35102b48b","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:2dfba404-3d8e-42d9-a69c-78f35102b48b_variant_evidence_item"},{"id":"cggv:2dfba404-3d8e-42d9-a69c-78f35102b48b_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Figure 4: For the mutant proteins RPGRIP1L-T615P and RPGRIP1L-T677I, the interaction was markedly reduced compared with the RPGRIP1L-WT or the RPGRIP1L-A695P mutant."}],"strengthScore":0.5},{"id":"cggv:1a46845e-fede-415f-a8e6-2e13ec70c7c2","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:1a46845e-fede-415f-a8e6-2e13ec70c7c2_variant_evidence_item"}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:04d40da7-890a-4d6b-ace3-65c39d86990b_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:04d40da7-890a-4d6b-ace3-65c39d86990b","type":"Proband","allele":[{"id":"cggv:bf593f8f-2159-4269-b3a0-3806377626ef"},{"id":"cggv:9a399b18-2799-410a-bf3f-6329742cd2bd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015272.5(RPGRIP1L):c.757C>T (p.Gln253Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251691"}}],"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002650","obo:HP_0001251","obo:HP_0000508","obo:HP_0002419","obo:HP_0002186","obo:HP_0001249","obo:HP_0000090","obo:HP_0003774"],"secondTestingMethod":"Linkage analysis","sex":"UnknownEthnicity","variant":[{"id":"cggv:028204b3-b181-40bf-a1c2-0ddfc65ceb5c_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:9a399b18-2799-410a-bf3f-6329742cd2bd"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558409"},{"id":"cggv:a730f634-e344-43b4-88be-8b252daccaae_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:bf593f8f-2159-4269-b3a0-3806377626ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558409"}],"rdfs:label":"F58-1"},{"id":"cggv:028204b3-b181-40bf-a1c2-0ddfc65ceb5c","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:028204b3-b181-40bf-a1c2-0ddfc65ceb5c_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:a730f634-e344-43b4-88be-8b252daccaae","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:a730f634-e344-43b4-88be-8b252daccaae_variant_evidence_item"},{"id":"cggv:a730f634-e344-43b4-88be-8b252daccaae_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"For the mutant proteins RPGRIP1L-T615P and RPGRIP1L-T677I, the interaction was markedly reduced compared with the RPGRIP1L-WT or the RPGRIP1L-A695P mutant."}],"strengthScore":0,"dc:description":"The variant is already scored"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:4c21e346-2849-46a6-b538-5a713e20b2ce_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:4c21e346-2849-46a6-b538-5a713e20b2ce","type":"Proband","allele":{"id":"cggv:0f4665b3-7fd8-4a83-950c-89975cba20b2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015272.5(RPGRIP1L):c.394A>T (p.Arg132Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA114729"}},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0100259","obo:HP_0002085","obo:HP_0002323","obo:HP_0410030","obo:HP_0000107","obo:HP_0001408","obo:HP_0000568"],"secondTestingMethod":"Linkage analysis","sex":"UnknownEthnicity","variant":{"id":"cggv:3a870165-fe47-49d6-b92d-7b538247f18b_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:0f4665b3-7fd8-4a83-950c-89975cba20b2"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558409"},"rdfs:label":"F1MKS 03/107"},{"id":"cggv:3a870165-fe47-49d6-b92d-7b538247f18b","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:3a870165-fe47-49d6-b92d-7b538247f18b_variant_evidence_item"}],"strengthScore":1,"dc:description":"downgraded because of homozygosity"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:cbb84205-336f-490f-a5f1-86e84e76104a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:cbb84205-336f-490f-a5f1-86e84e76104a","type":"Proband","allele":[{"id":"cggv:d3ff87b1-a463-474d-a6d4-335e0debf0ae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015272.5(RPGRIP1L):c.2050C>T (p.Gln684Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA251696"}},{"id":"cggv:bf593f8f-2159-4269-b3a0-3806377626ef"}],"firstTestingMethod":"Chromosomal microarray","phenotypes":["obo:HP_0012758","obo:HP_0010442","obo:HP_0000508","obo:HP_0002419","obo:HP_0000496"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"cggv:d321fd69-ae6d-4a1a-a7af-5b0dad66d4b6_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d3ff87b1-a463-474d-a6d4-335e0debf0ae"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558407"},{"id":"cggv:f29e1e55-e394-4a13-9d99-992fdc312163_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:bf593f8f-2159-4269-b3a0-3806377626ef"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17558407"}],"rdfs:label":"UW15, II-3"},{"id":"cggv:d321fd69-ae6d-4a1a-a7af-5b0dad66d4b6","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:d321fd69-ae6d-4a1a-a7af-5b0dad66d4b6_variant_evidence_item"},{"id":"cggv:d321fd69-ae6d-4a1a-a7af-5b0dad66d4b6_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Sup Fig 6: Binding of nephrocystin-4 with RPGRIP1L is severely disrupted if RPGRIP1L\ncontains either of the Joubert syndrome-associated mutations we identified in the UW15\nfamily: nonsense mutation p.Gln684X and the missense mutation p.Thr615Pro."}],"strengthScore":2},{"id":"cggv:f29e1e55-e394-4a13-9d99-992fdc312163","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:f29e1e55-e394-4a13-9d99-992fdc312163_variant_evidence_item"},{"id":"cggv:f29e1e55-e394-4a13-9d99-992fdc312163_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Sup Fig 6: Binding of nephrocystin-4 with RPGRIP1L is severely disrupted if RPGRIP1L\ncontains either of the Joubert syndrome-associated mutations we identified in the UW15\nfamily: nonsense mutation p.Gln684X and the missense mutation p.Thr615Pro."}],"strengthScore":0,"dc:description":"The variant has already been scored"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":8663,"specifiedBy":"GeneValidityCriteria10","strengthScore":18,"subject":{"id":"cggv:ecf096a8-1c75-44a5-90e9-83395965a956","type":"GeneValidityProposition","disease":"obo:MONDO_0005308","gene":"hgnc:29168","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"The *RPGRIP1L* gene is located on chromosome 16 at 16q12.2 and encodes the retinitis pigmentosa GTPase regulator-interacting protein (RPGRIP1) -like. It helps control the assembly of the ciliary transition zone, positively regulates proteasomal activity at the ciliary base, and governs autophagy via regulating mTOR signaling. It is ubiquitously expressed at varying levels in all tissues. Multiple disease entities have been reported in association with this gene, but per criteria outlined by the ClinGen Lumping and Splitting Working Group, there was no evidence of differences in their molecular mechanisms, inheritance pattern, and phenotypic spectrum. Therefore, the following disease entities have been lumped into one disease entity: Joubert syndrome 7 (OMIM:611560), Meckel syndrome 5 (OMIM:611561), and COACH syndrome 3 (OMIM:619113). The preferred disease name suggested for this disorder is autosomal recessive ciliopathy. \n\n*RPGRIP1L* was first reported in relation to autosomal recessive ciliopathy in 2007 (Delous et al., PMID: 17558409 and Arts et al., PMID: 17558407). The mechanism of pathogenicity appears to be loss of function. Patients with biallelic RPGRIP1L pathogenic variants presented with clinical features consistent with ciliopathies, including neurodevelopmental delay, molar tooth sign on brain MRI, encephalocele, ocular coloboma, oculomotor apraxia, cerebellar ataxia, cystic kidney disease, nephronophthisis, liver disease, and polydactyly.\n\nAt least 10 variants (missense, nonsense, frameshift, splice site) have been reported in eight probands in two publications (PMIDs: 17558409, 17558407) included in this curation. The majority of the variants were loss of function variants.  Functional data supports the pathogenicity of the missense variants (PMIDs: 17558409, 17558407). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) was reached, considering case-level data. \n\nThis gene-disease relationship is also supported by functional studies, expression studies, in vitro assays in non-patient cells, and animal models. RPGRIP1L is expressed in multiple organs, including brain, forelimbs, and kidneys (PMID: 17558409). The encoded protein interacts with another ciliopathy protein, nephrocystin-4 (PMID: 17558409), regulates components of the NPHP modules at the ciliary transition zone, and is essential for the assembly of the transition zone in human embryonic kidney cells (PMID: 29650680). Knockout model organisms recapitulate ciliopathy features including kidney cysts, and central nervous system abnormalities (PMID: 17558409, 29650680). More evidence is available in the literature, but the maximum score for experimental evidence (6 pts.) was reached.\n\nIn summary, there is definitive evidence supporting the relationship between *RPGRIP1L* and autosomal recessive ciliopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders Expert Panel GCEP on the meeting date [April, 24, 2024] (SOP Version 10).\n","dc:isVersionOf":{"id":"cggv:ab4cfcff-be99-4c82-ab33-8451b5ed5b0c"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}